Santen
Peter Sallstig serves as the President and CEO of Santen Inc. in the USA, while also holding the role of Global Head of the Product Development Division and Chief Medical Officer. With extensive experience in managing global development operations across multiple regions, including Japan, the USA, Europe, and China, Peter has successfully led diverse teams and overseen significant initiatives in organizations such as Insmed Incorporated, Alcon, Bristol-Myers Squibb, and Novartis. Notable achievements include transforming the Development Department at Santen, overseeing clinical programs at Insmed, and repositioning immunology compounds at Bristol-Myers Squibb. Peter Sallstig holds a Doctor of Medicine degree from Semmelweis University and an MBA from The Open University.
Santen
7 followers
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.